Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Jiangsu Aidea Pharmaceutical Co Ltd cash flow-to-debt ratio. Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥3.56 Million could theoretically repay 0% of its total liabilities (CN¥762.97 Million) in one year. Check how aggressively does Jiangsu Aidea Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)
Cash flow-to-debt ratio of Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2025. Historical debt coverage capacity for Jiangsu Aidea Pharmaceutical Co Ltd across 10 annual periods. Check how high is Jiangsu Aidea Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2016–2025)
Jiangsu Aidea Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Jiangsu Aidea Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Jiangsu Aidea Pharmaceutical Co Ltd generate cash.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | CN¥17.63 Million | CN¥839.37 Million | ▲ +145.0% |
| 2024 | -0.05x | CN¥-37.50 Million | CN¥802.48 Million | ▲ +82.5% |
| 2023 | -0.27x | CN¥-166.22 Million | CN¥621.03 Million | ▼ -31.9% |
| 2022 | -0.20x | CN¥-92.55 Million | CN¥456.23 Million | ▼ -104.7% |
| 2021 | -0.10x | CN¥-12.37 Million | CN¥124.82 Million | ▼ -115.3% |
| 2020 | 0.65x | CN¥56.17 Million | CN¥86.97 Million | ▲ +158.3% |
| 2019 | 0.25x | CN¥56.20 Million | CN¥224.74 Million | ▲ +239.0% |
| 2018 | -0.18x | CN¥-33.50 Million | CN¥186.24 Million | ▲ +61.1% |
| 2017 | -0.46x | CN¥-67.18 Million | CN¥145.14 Million | ▼ -311.8% |
| 2016 | 0.22x | CN¥31.29 Million | CN¥143.16 Million | — |